Anusha Sinha

Introduction Resolving an Out-of-Specification Impurity Result during therapeutic peptide manufacturing requires a systematic analytical and regulatory approach to identify the […]

Introduction Converting a peptide active pharmaceutical ingredient (API) from the trifluoroacetate (TFA) form to an acetate salt is an important

Introduction A thorough Extractables and Leachables Assessment of a peptide prefilled syringe generates the empirical chemical data necessary to support

Introduction Conducting a comprehensive Nitrosamine Risk Assessment and Trace-Level NDSRI Testing program is an essential regulatory and quality requirement for

Introduction Research-grade peptides and Good Manufacturing Practice (GMP) peptides represent two distinct categories of materials because they are manufactured under

Introduction Peptide drugs require specialized cold-chain infrastructure because their dynamic amino acid structures and chemically reactive side chains are highly

Introduction The minimum batch size for GMP peptide manufacturing is primarily determined by equipment working volumes, mandatory analytical release testing

Introduction A single qualified contract manufacturing organization can manufacture both active pharmaceutical ingredient (API) drug substance and finished drug product

Introduction Essential Peptide CDMO Certifications encompass mandatory regulatory accreditations, including Current Good Manufacturing Practice (cGMP) compliance under ICH Q7 guidelines,